Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex

BACKGROUND: To determine the impact of metabolic syndrome (MetS) and/or metabolic dysfunction-associated fatty liver disease (MAFLD), which are pathophysiologically similar and include insulin resistance, on the development of new-onset cardiovascular disease with and without type 2 diabetes and acc...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsubayashi, Yasuhiro, Fujihara, Kazuya, Yamada-Harada, Mayuko, Mitsuma, Yurie, Sato, Takaaki, Yaguchi, Yuta, Osawa, Taeko, Yamamoto, Masahiko, Kitazawa, Masaru, Yamada, Takaho, Kodama, Satoru, Sone, Hirohito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161475/
https://www.ncbi.nlm.nih.gov/pubmed/35655263
http://dx.doi.org/10.1186/s12933-022-01518-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161475/
https://www.ncbi.nlm.nih.gov/pubmed/35655263
http://dx.doi.org/10.1186/s12933-022-01518-4

Ejemplares similares